Current Report Filing (8-k)
April 22 2019 - 8:31AM
Edgar (US Regulatory)
United
States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
April 22, 2019
China Jo-Jo Drugstores, Inc.
(Exact name of Registrant as specified in charter)
Nevada
|
|
001-34711
|
|
98-0557852
|
(State or other jurisdiction
of Incorporation)
|
|
(Commission File No.)
|
|
(IRS Employer
Identification No.)
|
Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District
Hangzhou City, Zhejiang Province, People’s
Republic of China, 310008
(Address of principal executive offices) (Zip
Code)
Registrant's telephone number, including area
code:
+86 (571) 88219579
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to
Rule 425 under the Securities Act (17CFR230.425)
☐ Soliciting material pursuant to Rule14a-12
under the Exchange Act (17CFR240.14a-12)
☐ Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
☐ Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01.
|
Regulation FD Disclosure.
|
On April 22, 2019, China Jo-Jo Drugstores,
Inc. issued a press release providing the updates to its corporate strategy for 2019. The full text of the press release is attached
as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits.
__________
1
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: April 22, 2019
|
CHINA JO-JO DRUGSTORES, INC.
|
|
|
|
|
By:
|
/s/ Lei Liu
|
|
Name:
|
Lei Liu
|
|
Title:
|
Chief Executive Officer
|
China Jo Jo Drugstores (NASDAQ:CJJD)
Historical Stock Chart
From Aug 2024 to Sep 2024
China Jo Jo Drugstores (NASDAQ:CJJD)
Historical Stock Chart
From Sep 2023 to Sep 2024